دورية أكاديمية
أعرض في EDS

Clinical characteristics and outcomes of patients with severe acute respiratory infections (SARI): results from the Egyptian surveillance study 2010-2014.

التفاصيل البيبلوغرافية
العنوان: Clinical characteristics and outcomes of patients with severe acute respiratory infections (SARI): results from the Egyptian surveillance study 2010-2014.
المؤلفون: Hatem A; 1Department of Chest Diseases, Faculty of Medicine, Cairo University, Cairo, Egypt., Mohamed S; 2Department of Chest Diseases and Tuberculosis, Faculty of Medicine, Assiut University, Assiut, 71516 Egypt., Abu Elhassan UE; 1Department of Chest Diseases, Faculty of Medicine, Cairo University, Cairo, Egypt., Ismael EAM; 1Department of Chest Diseases, Faculty of Medicine, Cairo University, Cairo, Egypt., Rizk MS; 3Department of Anesthesia and Intensive Care, Faculty of Medicine, Cairo University, Cairo, Egypt., El-Kholy A; 4Department of Clinical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt., El-Harras M; Department of Clinical Pathology, Faculty of Medicine, Mansura University, Mansura, Egypt.
المصدر: Multidisciplinary respiratory medicine [Multidiscip Respir Med] 2019 Apr 01; Vol. 14, pp. 11. Date of Electronic Publication: 2019 Apr 01 (Print Publication: 2019).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Mattioli1885 Country of Publication: Italy NLM ID: 101477642 Publication Model: eCollection Cited Medium: Print ISSN: 1828-695X (Print) Linking ISSN: 1828695X NLM ISO Abbreviation: Multidiscip Respir Med Subsets: PubMed not MEDLINE
أسماء مطبوعة: Publication: 2024- : Fidenza, Italy : Mattioli1885
Original Publication: Borgomanero : Novamedia
مستخلص: Background: Respiratory viral and atypical bacterial infections data in Egyptian patients are sparse. This study describes the clinical features and outcomes of patients with severe acute respiratory infections (SARI) in hospitalized patients in Egypt.
Methods: SARI surveillance was implemented at Cairo University Hospital (CUH) during the period 2010-2014. All hospitalized patients meeting the WHO case definition for SARI were enrolled. Nasopharyngeal/oropharyngeal (NP/OP) swabs were collected and samples were tested using RT-PCR for influenza A, B, respiratory syncytial virus (RSV), human metapneumovirus (hMPV), parainfluenza virus (PIV 1,2,3,4), adenovirus, bocavirus, coronavirus, enterovirus, rhinovirus, and atypical bacteria. Data were analyzed to calculate positivity rates for viral pathogens and determine which pathogens related to severe outcomes or resulted in death.
Results: Overall, 1,075/3,207 (33.5%) cases had a viral etiology, with a mean age of 5.74 (±13.87) years. The highest rates were reported for RSV (485 cases, 45.2%), PIV (125, 11.6%), and adenovirus (105, 9.8%). Children had a higher viral rate (981, 91.2%) compared to 94 (8.8%) cases in adults. Patients with identified viruses had significantly lower rates for ICU admission, hospital stay, mechanical ventilation, and overall mortality than those without identified viruses. No infections were independently associated with severe outcomes.
Conclusions: Viral pathogens were encountered in one-third of hospitalized adult and pediatric Egyptian patients with SARI, while atypical bacteria had a minor role. Highest rates of viral infections were reported for RSV, PIV, and adenovirus. Viral infections had neither negative impacts on clinical features nor outcomes of patients with SARI in our locality.
Competing Interests: The study protocol was approved by the Institutional Review Board at the NAMRU-3, as well as the ethical committee of Cairo University Hospital (CUH), in compliance with all applicable federal U.S. regulations governing the protection of human subjects. Informed written consent was obtained from the patients (in the case of adult patients) or patients’ parent/legal guardian (in the case of pediatric patients).Not applicable.The authors declare that they have no competing interests.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References: Clin Infect Dis. 2003 Dec 15;37(12):1668-77. (PMID: 14689350)
N Engl J Med. 2004 Jan 29;350(5):443-50. (PMID: 14749452)
J Clin Virol. 2006 Jan;35(1):46-50. (PMID: 15919236)
Turk J Pediatr. 2005 Jul-Sep;47(3):227-31. (PMID: 16250306)
Pediatr Infect Dis J. 2007 Nov;26(11 Suppl):S36-40. (PMID: 18090198)
Arch Intern Med. 2008 Dec 8;168(22):2489-96. (PMID: 19064834)
Clin Microbiol Rev. 2010 Jan;23(1):74-98. (PMID: 20065326)
Lancet. 2010 May 1;375(9725):1545-55. (PMID: 20399493)
J Med Virol. 2010 May;82(6):1012-6. (PMID: 20419816)
J Clin Microbiol. 2011 Jul;49(7):2631-6. (PMID: 21543571)
PLoS One. 2012;7(8):e43656. (PMID: 22937071)
BMC Infect Dis. 2012 Dec 13;12:350. (PMID: 23237512)
Pediatr Int. 2013 Jun;55(3):283-8. (PMID: 23316763)
PLoS One. 2013 Aug 22;8(8):e72606. (PMID: 23991128)
Mediterr J Hematol Infect Dis. 2013 Sep 02;5(1):e2013056. (PMID: 24106606)
Am J Respir Crit Care Med. 2014 Feb 15;189(4):449-62. (PMID: 24308446)
J Med Virol. 2015 Feb;87(2):275-80. (PMID: 25074284)
J Infect Dev Ctries. 2014 Oct 15;8(10):1285-93. (PMID: 25313605)
J Infect Dis. 2015 May 15;211(10):1550-9. (PMID: 25425699)
BMC Infect Dis. 2015 Jan 08;15:1. (PMID: 25567701)
BMC Infect Dis. 2015 Feb 25;15:95. (PMID: 25879805)
Influenza Other Respir Viruses. 2016 May;10(3):161-9. (PMID: 26590069)
PLoS One. 2016 Mar 10;11(3):e0150776. (PMID: 26964038)
Jpn J Infect Dis. 2017 Sep 25;70(5):522-527. (PMID: 28367882)
PLoS One. 2017 Jul 13;12(7):e0180954. (PMID: 28704440)
فهرسة مساهمة: Keywords: Clinical; Egypt; Outcomes; SARI; Surveillance; Viral
تواريخ الأحداث: Date Created: 20190413 Latest Revision: 20220408
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC6442424
DOI: 10.1186/s40248-019-0174-7
PMID: 30976418
قاعدة البيانات: MEDLINE
الوصف
تدمد:1828-695X
DOI:10.1186/s40248-019-0174-7